VytronUS Raises Funds, Loses CEO To New Abbott EP Biz
This article was originally published in The Gray Sheet
Executive Summary
The cardiac arrhythmia ablation device firm raised $31.6 million in a Series B financing, the same day its CEO was announced to be leaving for Abbott's new electrophysiology unit.